A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer
Clinical trial NCT04890795 · UNKNOWN
Trial details
- NCT number
- NCT04890795
- Sponsor
- Advenchen Laboratories Nanjing Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2021-09-01
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.